Marlowe PLC Holding(s) in Company
December 09 2024 - 2:14AM
RNS Regulatory News
RNS Number : 3196P
Marlowe PLC
09 December 2024
9 December 2024
Marlowe plc
Holding(s) in
Company
Marlowe plc ("Marlowe" or the "Group"), the leader in
business-critical services, announces that it has today been
notified, in accordance with the Financial Conduct Authority's
Disclosure Guidance and Transparency Rules and as a result of the
repurchase and cancellation by the Company of Ordinary Shares in
accordance with the terms of Marlowe's buyback programme announced
on 22 May 2024, that Lord Michael Ashcroft KCMG PC, Interim
Non-Executive Chairman of Marlowe, crossed a notifiable threshold
in his percentage shareholding of ordinary shares of 50 pence each
in the Company ("Ordinary
Shares") on 6 December 2024.
Lord Ashcroft PCMG PC remains
beneficially interested in an unchanged 15,310,170 Ordinary Shares,
now representing 18.11 per cent. of the Group's issued ordinary
share capital.
For
further information:
|
|
|
|
Marlowe plc
|
|
Lord Ashcroft, Interim Non-Executive
Chair
Adam Councell, Chief Financial
Officer
Benjamin Tucker, Head of Investor
Relations & Strategy
|
www.marloweplc.com
Tel: +44
(0)20 3813 8498
IR@marloweplc.com
|
Cavendish Capital Markets Limited (Nominated Adviser &
Broker)
|
Ben Jeynes
George Lawson
|
Tel: +44
(0)20 7220 0500
|
|
|
FTI
Consulting
|
|
Nick Hasell
Alex Le May
|
Tel: +44
(0)20 3727 1340
|
About Marlowe plc
Marlowe is a leader in
business-critical services which ensures compliance with strict
regulations and insurance requirements across Fire Safety &
Security and Water & Air Hygiene. The Group has a national
footprint and serves approximately 27,000 customers across office
complexes, high streets & leisure facilities, manufacturing
plants and industrial estates, and include thousands of SMEs, local
authorities, facilities management providers, multi-site NHS trusts
and FTSE 100 companies.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
HOLQKCBDFBDKBBK
Marlowe (LSE:MRL)
Historical Stock Chart
From Nov 2024 to Dec 2024
Marlowe (LSE:MRL)
Historical Stock Chart
From Dec 2023 to Dec 2024